Literature DB >> 19546239

Modulation of the partition coefficient between octanol and buffer at pH 7.4 and pKa to achieve the optimum balance of blood clearance and volume of distribution for a series of tetrahydropyran histamine type 3 receptor antagonists.

Tanya Hay1, Rhys Jones, Kevin Beaumont, Mark Kemp.   

Abstract

The relationship between rat pharmacokinetics and physicochemical parameters [the partition coefficient between octanol and buffer at pH 7.4 (log D((7.4))) and pK(a)] was studied for a series of tetrahydropyran compounds. Sixteen compounds ranging in log D((7.4)) 0.1 to 1.8 were administered intravenously to rats, and the pharmacokinetic parameters were determined from blood concentration time curves. Across the series, a weak correlation was observed between log D((7.4)) and blood clearance, suggesting that log D((7.4)) values less than 0.5 were required to prevent clearance at hepatic blood flow. In terms of the volume of distribution (V(d)), the compounds fell into three distinct subseries characterized by the number of basic centers and differences in ionization of each basic center at physiological pH. These were referred to as the monobasic, weak second base, and strong second base subseries. All the compounds exhibited V(d) greater than body water, as would be expected from their lipophilic and basic nature. For a given clog P, the strong second base subseries showed higher V(d) than the weak second base subseries, which in turn exhibited higher values than the monobasic subseries. In addition, for the weak second base subseries, V(d) could be tuned by modulating the pK(a) of the second basic center. This relationship was rationalized in respect to the interactions of the ionizable centers with phospholipid heads in the cell membrane and/or lysosomal trapping. Compounds in the weak second base subseries showed optimal V(d), and when combined with a log D((7.4)) of 0.1, driving to moderate blood clearance, one compound showed the optimal pharmacokinetic profile.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19546239     DOI: 10.1124/dmd.109.027888

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

1.  Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability.

Authors:  Martin Pettersson; Douglas S Johnson; John M Humphrey; Todd W Butler; Christopher W Am Ende; Benjamin A Fish; Michael E Green; Gregory W Kauffman; Patrick B Mullins; Christopher J O'Donnell; Antonia F Stepan; Cory M Stiff; Chakrapani Subramanyam; Tuan P Tran; Beth Cooper Vetelino; Eddie Yang; Longfei Xie; Kelly R Bales; Leslie R Pustilnik; Stefanus J Steyn; Kathleen M Wood; Patrick R Verhoest
Journal:  ACS Med Chem Lett       Date:  2015-04-03       Impact factor: 4.345

2.  Permeability comparison between hepatocyte and low efflux MDCKII cell monolayer.

Authors:  Rui Li; Yi-An Bi; Yurong Lai; Kiyohiko Sugano; Stefanus J Steyn; Patrick E Trapa; Li Di
Journal:  AAPS J       Date:  2014-05-23       Impact factor: 4.009

3.  In Vitro - in Vivo Extrapolation of Hepatic Clearance in Preclinical Species.

Authors:  David A Tess; Sangwoo Ryu; Li Di
Journal:  Pharm Res       Date:  2022-03-07       Impact factor: 4.200

4.  Discovery and in Vitro Optimization of 3-Sulfamoylbenzamides as ROMK Inhibitors.

Authors:  Matthew F Sammons; Sujay V Kharade; Kevin J Filipski; Markus Boehm; Aaron C Smith; Andre Shavnya; Dilinie P Fernando; Matthew S Dowling; Philip A Carpino; Neil A Castle; Shannon G Zellmer; Brett M Antonio; James R Gosset; Anthony Carlo; Jerod S Denton
Journal:  ACS Med Chem Lett       Date:  2018-01-19       Impact factor: 4.345

5.  Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacy.

Authors:  Martin Pettersson; Douglas S Johnson; Danica A Rankic; Gregory W Kauffman; Christopher W Am Ende; Todd W Butler; Brian Boscoe; Edelweiss Evrard; Christopher J Helal; John M Humphrey; Antonia F Stepan; Cory M Stiff; Eddie Yang; Longfei Xie; Kelly R Bales; Eva Hajos-Korcsok; Stephen Jenkinson; Betty Pettersen; Leslie R Pustilnik; David S Ramirez; Stefanus J Steyn; Kathleen M Wood; Patrick R Verhoest
Journal:  Medchemcomm       Date:  2016-11-02       Impact factor: 3.597

6.  Synthesis, antibiotic modifying activity, ADMET study and molecular docking of chalcone (E)-3-(2,4-dichlorophenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one in strains of Staphylococcus aureus carrying MepA efflux pumps.

Authors:  Janaína Esmeraldo Rocha; Thiago Sampaio de Freitas; Jayze da Cunha Xavier; Raimundo Luiz Silva Pereira; Francisco Nascimento Pereira; Carlos Emídio Sampaio Nogueira; Márcia Machado Marinho; Paulo Nogueira Bandeira; Maria Alyce Albuquerque Fernandes; Emmanuel Silva Marinho; Alexandre Magno Rodrigues Teixeira; Hélcio Silva Dos Santos; Henrique Douglas Melo Coutinho
Journal:  Arch Microbiol       Date:  2021-12-23       Impact factor: 2.552

7.  Lysosomal trapping of palbociclib and its functional implications.

Authors:  Susana Llanos; Diego Megias; Carmen Blanco-Aparicio; Elena Hernández-Encinas; Miguel Rovira; Federico Pietrocola; Manuel Serrano
Journal:  Oncogene       Date:  2019-01-28       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.